Verastem Inc (NASDAQ:VSTM) has been engaging in the discovery and development of drugs for cancer patients for many years. Its drugs have helped in improving both the survival as well as the quality of life of the various cancer patients globally. Today, the top provider has happily announced the appointment of its new Chief Financial Officer, Julie B. Feder.
In welcoming her, the President and Chief Executive Officer of Verastem, Robert Forrester said, “Julie is an accomplished financial professional with invaluable leadership experience in healthcare, having served as Chief Financial Officer of the Clinton Health Access Initiative and in finance roles of increasing responsibility at Genzyme. We are delighted to welcome her to our executive team as we look forward to the final data readout of our Phase 3 DUO study evaluating duvelisib in chronic lymphocytic leukemia.”
Ms. Feder seemed very much thrilled by the opportunity to work for the top company. She outlined that it was indeed an honor to be joining Verastem Inc’s management team during a moment when the company was performing fairly well.
She affirmed that the company had all it took to grow and become a commercial-stage provider that would indeed deliver top end services to patients struggling with lymphoid malignancies. Ms. Feder has expressed her commitment to work closely with the provider’s leadership team to help achieve both strategic and financial goals.
Some reliable sources indicate that she served in a wide range of companies in the top positions helping them make tremendous steps forward.
At Deloitte & Touche LLP, she served in the capacity of the provider’s Senior Manager of Audit, Consulting and Enterprise Risk Services. The top executive will be remembered for being a major team player who coordinated the rest of the company’s employees in quite a remarkable fashion.
Her great efforts were seen through the major progress the company made in terms of implementing major expansions. Ms. Feder is a shining star and Verastem Inc looks forward to achieving so much with her appointment according to Yahoo.